“…There are increasing numbers of studies that discuss the importance of ADO in DNA diagnostic procedures (Tester et al, 2006;Coulet et al, 2010;Medlock et al, 2012;Rossetti et al, 2012;Lam and Mak, 2013;Shmukler et al, 2013;Rhees et al, 2014;Blais et al, 2015;Proost, 2016). This phenomenon was detected in oncogenetics (BRCA1/2 testing), inborn metabolic disease genotyping (FAH testing), hematology research etc (Lam and Mak, 2013;Shmukler et al, 2013;Jeong et al, 2019). We surmise that the actual number of ADO events remains unknown and may significantly exceed the events actually detected.…”